Abnova (Taiwan) Corporation operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Abnova (Taiwan) with three other
companies in this sector in Taiwan:
sales of 253.11 million Taiwanese Dollars [US$8.39 million]
(606.73 million Taiwanese Dollars [US$20.11 million]
of which 100%
was Medicines), and
Genmont Biotech Inc
(540.78 million Taiwanese Dollars [US$17.93 million]
of which 64%
was Jingyue Company).
During the year ended December of 2016, sales at
Abnova (Taiwan) were 439.83 million Taiwanese Dollars (US$14.58 million).
decrease of 2.6%
versus 2015, when the company's sales were 451.37 million Taiwanese Dollars.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Abnova (Taiwan) had sales
of 472.57 million Taiwanese Dollars.